| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 10/15/2008 | EP1979322A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity |
| 10/15/2008 | EP1979321A1 Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them |
| 10/15/2008 | EP1979320A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS |
| 10/15/2008 | EP1979311A2 Phenoxy acetic acids as ppar delta activators |
| 10/15/2008 | EP1896416B1 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them |
| 10/15/2008 | EP1781297B1 Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 10/15/2008 | EP1742642B1 Phosphonate analogs of hiv integrase inhibitor compounds |
| 10/15/2008 | EP1532158B1 Neutral metallic dendrimer complexes |
| 10/15/2008 | EP1476423B1 Arylsulfonamidobenzylic compounds |
| 10/15/2008 | EP1385912B1 Pyridone dyes, a process for their preparation and their use in the production of coloured plastics or polymeric colour particles |
| 10/15/2008 | EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 10/15/2008 | EP1308436B1 Calcium receptor antagonists |
| 10/15/2008 | CN101287718A Substituted heteroaryl- and phenylsulfamoyl compounds |
| 10/15/2008 | CN101287708A Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4) |
| 10/15/2008 | CN101287707A 激酶抑制剂 Kinase inhibitors |
| 10/15/2008 | CN101287702A N-phenyl phenylacetamide non-nucleoside reverse transcriptase inhibitors |
| 10/15/2008 | CN101284865A New compound and its medicine use |
| 10/15/2008 | CN101284779A Preparation method of (E)-4-(beta-bromovinyl)phenol ester |
| 10/15/2008 | CN101284247A Dinuclear nickel cross-coupling reaction catalyst supported by nitrogen heterocycle carbine ligand and preparation method thereof |
| 10/15/2008 | CN100425609C N-heteroarylnicotinamide derivatives |
| 10/15/2008 | CN100425607C Method for controlling particular insects by applying anthranilamide compounds |
| 10/14/2008 | US7435844 Fungicides; 2-methoxyacrylic acid esters or amides, 2-substituted with o-(phenoxymethyl)phenyl- groups, e.g., methyl (E)-2-{2-[3,5-dichloro-4-(3,3-dimethylbutoxy)phenoxymethyl]phenyl}-3-methoxyacrylate; agriculture, horticulture, animal husbandry |
| 10/14/2008 | US7435843 Thiobenzoic acid, N-malonylhydrazide in which the free carboxy group is protected; enhances the desirable tumor attacking properties of anticancer agents without further increasing undesirable side-effects |
| 10/14/2008 | US7435823 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer |
| 10/14/2008 | US7435815 Sulfonylamino-acetic acid derivatives |
| 10/14/2008 | US7435743 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one |
| 10/14/2008 | CA2333089C Processes and intermediates for preparing 2-substituted piperidine stereoisomers |
| 10/14/2008 | CA2309328C Cyclic amine derivatives and their use as drugs |
| 10/09/2008 | WO2008120810A1 Compound, photoelectric converter and photoelectrochemical cell |
| 10/09/2008 | WO2008120759A1 Urea compound and use thereof |
| 10/09/2008 | WO2008120754A1 Picolinamide compound |
| 10/09/2008 | WO2008120235A1 Novel benzophenone hybrids as potential anticancer agents and a process for the preparation thereof |
| 10/09/2008 | WO2008119773A1 Amide derivatives as inhibitors of aspartyl proteases |
| 10/09/2008 | WO2008101682A3 Iminipyridine derivatives and their uses as microbiocides |
| 10/09/2008 | WO2008062276A8 Acetylene derivatives as stearoyl coa desaturase inhibitors |
| 10/09/2008 | WO2008024304A3 Compounds for treatment of proliferative disorders |
| 10/09/2008 | WO2007124424A3 Il-8 receptor antagonists |
| 10/09/2008 | WO2007107706A3 Dimers of heterocyclic compounds for the treatment of copd |
| 10/09/2008 | US20080249314 Using isopropanol solvent and dibenzolytartaric acid; forming salt; reacting with a base |
| 10/09/2008 | US20080249313 Heating mixture of trichloromethylpyridine with sulfuric acid in liquid phase |
| 10/09/2008 | US20080249306 Method for the Production of Statins |
| 10/09/2008 | US20080249166 Inhibiting hepatic fatty acid and sterol synthesis; use with statins; compounds such as cyclopropyl or cyclobutyl-functional hydroxy-functional alpha,gamma-alkanediacids |
| 10/09/2008 | US20080249140 Quaternary 3 -Amido, N-Methylpyridinium Salts as Anti-Inflammatory Agents |
| 10/09/2008 | US20080249139 N-((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)pyrazine-2-carboxamide for example; or corresponding sulfonamides; beta-secretase inhibitors; dementia; Alzheimer's disease |
| 10/09/2008 | US20080249138 Pyridine Compounds For The Treatment Of Prostaglandin Mediated Diseases |
| 10/09/2008 | US20080249137 e.g. {3-butoxy-5-[4-(4-trifluoromethoxy-phenoxy)-benzenesulfonyl]-phenyl}-acetic acid; peroxisome proliferator activated receptor modulator; antidiabetic agent; obesity, hyperlipidemia, dyslipidemia, hypertriglyceridemia, Syndrome X, insulin resistance, diabetic neuropathy, atherosclerosis, eczema |
| 10/09/2008 | US20080249102 Hiv Protease Inhibitors |
| 10/09/2008 | US20080249093 immunosuppressive, anti-inflammatory and hemostatic agents to modulate leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity; safer and more effective; 3-(4-(5-(3-Cyano-4-isopropyloxyphenyl)-1,2,4-oxadiazol-3-yl)-3-methylphenyl)propanoic acid |
| 10/09/2008 | US20080249071 inhibitory activity against the activation of inflammatory cytokines such as interleukin (IL)-1, IL-6, IL-8 and tumor necrosis factor (TNF- alpha ), NF- kappa K B; inflammatory disorders, autoimmune diseases; side effects reduction; immuno suressants; N-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxybenzamide |
| 10/09/2008 | US20080248329 Light sources comprising organic light emmiters between electrodes, used in displaying, electrophotography, recording, exposure, signs or optical communications; brightness; efficiency; durability; iridium complex |
| 10/09/2008 | US20080246002 Polar liquid crystal |
| 10/09/2008 | CA2682384A1 Benzophenone hybrids as potential anticancer agents and a process for the preparation thereof |
| 10/08/2008 | EP1977749A1 Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 10/08/2008 | EP1976840A1 Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators |
| 10/08/2008 | EP1654233A4 Method for the manufacture of cyanopyridines and catalysts suitable therefor |
| 10/08/2008 | EP1539693B9 Cannabinoid receptor agonists |
| 10/08/2008 | EP1341785B1 Hydrolysis of r(r*,r*)-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- [(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid esters with calcium hydroxide |
| 10/08/2008 | EP1335902B1 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 10/08/2008 | CN101282953A Therapeutic agents |
| 10/08/2008 | CN101282937A Therapeutic agents |
| 10/08/2008 | CN101282934A Triarylcarboxylic acid derivative |
| 10/08/2008 | CN101282933A Novel NK1 and NK2 antagonists |
| 10/08/2008 | CN101282786A Catalyst with bimodal distribution of the particles of the catalytically active material, method for the production thereof and for the regeneration thereof and the use of the catalyst |
| 10/08/2008 | CN101279969A Organic electroluminescent material and application thereof |
| 10/08/2008 | CN101279927A Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents |
| 10/08/2008 | CN100424083C Pyrimidine derivative compound and its preparing method |
| 10/08/2008 | CN100423721C Thrombopoietin mimetics |
| 10/07/2008 | US7432392 Ester derivatives and medical use thereof |
| 10/07/2008 | US7432378 For example, 2-{2-Chloro-4-[3-(4-methyl-piperazin-1-yl)-propoxy]-phenyl}-4,5-dimethyl-1H-benzoimidazole; use in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions |
| 10/07/2008 | US7432370 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying |
| 10/07/2008 | US7432303 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 10/07/2008 | US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors |
| 10/07/2008 | US7432287 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance |
| 10/07/2008 | US7432286 Pharmaceutically active sulfonyl hydrazide derivatives |
| 10/07/2008 | US7432281 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist |
| 10/07/2008 | US7432268 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 10/07/2008 | US7432264 Antibacterial compounds such as (S)-2-cyano-1-(trans-4-(5-nitro-2-pyridylamino)cyclohexylamino )acetylpyrrolidine; activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain |
| 10/07/2008 | US7432228 Applying a N-aryl(methyl)-p-hydroxy- or p-alkoxy--phenylalkylamine, e.g., 4-[2-(2-hydroxy-benzylamino)-ethyl]-phenol to inhibit 9-cis-epoxycarotenoid dioxygenase; plant growth regulators |
| 10/07/2008 | US7432227 6-alkyl or alkenyl-4-aminopicolinates and their use as herbicides |
| 10/07/2008 | CA2362831C Thioamide derivatives |
| 10/02/2008 | WO2008119015A2 Synthesis of thiohydantoins |
| 10/02/2008 | WO2008117862A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure |
| 10/02/2008 | WO2008117861A1 Intraocular pressure lowering agents containing phenylenediamine derivatives as the active ingredient |
| 10/02/2008 | WO2008116663A2 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments |
| 10/02/2008 | WO2008116301A1 Fluorinated derivatives of deferiprone |
| 10/02/2008 | WO2008093024A3 N-(amino-heteroaryl)-1h-pyrrolopyridine-2-carboxamides derivatives, preparation thereof and their use in therapy |
| 10/02/2008 | WO2008084223A3 Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors |
| 10/02/2008 | WO2008082500A3 Process for the synthesis of 2,6-diaminopyridines from glutarimidines |
| 10/02/2008 | WO2008075172A3 Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| 10/02/2008 | WO2008053194A3 Pyridine carboxamides as 11-beta-hsd1 inhibitors |
| 10/02/2008 | WO2007149163A3 Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors |
| 10/02/2008 | WO2007082098A8 6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides |
| 10/02/2008 | US20080242866 Synthesis of anthranilamides |
| 10/02/2008 | US20080242706 neurodegenerative diseases; to remove free iron or iron accumulation in neural tissues; iron chelators; improved chemical stability, penetration through blood brain barrier; reacting 3-hydroxy-4-pyridinone/3-hydroxy-4-pyranone derivatives; 1-cyclopropyl-2-difluoromethyl-5-hydroxy-1H-pyridin-4-one |
| 10/02/2008 | US20080242705 Fluridone as an Anti-Inflammatory Agent |
| 10/02/2008 | US20080242702 Paclitaxel enhancer compound |
| 10/02/2008 | US20080242698 Antiepilrptic agents; antiischemic agents; vision defects; skin disorders; muscular disorders; anticonvulsants;analgesics; Parkinson's disease; huntington's disease; amyotrophic lateral sclerosis; multiple sclerosis |
| 10/02/2008 | US20080242656 N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof |
| 10/02/2008 | US20080242593 Such as 2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(6-(2-ethylphenyl)pyridin-3-yl)propanoic acid; stability to proteolytic cleavage |
| 10/02/2008 | DE102007016139A1 Verfahren zur regioselektiven Oxygenierung von N-Heterozyklen Method for the regioselective oxygenation of N-heterocycles |